← Back to headlines
Fate Therapeutics Presents Lupus Treatment Data at Medical Conference
The immunotherapy company shared preliminary clinical results for its FT819 candidate targeting systemic lupus erythematosus.
9 Sept, 11:04 — 9 Sept, 11:04
Sources
Showing 1 of 1 sources
